News

BioM's articles and press releases about the Bavarian biotechnology sector


BIO-Japan 2025: Register now for the Bavarian Booth!

From 8 - 10 Octo­ber 2025, BIO-Japan will take place in Yoko­hama (Japan). For the second largest phar­ma­ceut­ic­al mar­ket in the world,…

Meliodays Medical secures EUR 800,000 for hormone-free treatment of menstrual pain

The Mu­nich-based start-up Meli­odays Med­ic­al has suc­cess­fully closed an over­sub­scribed pre-seed fin­an­cing round, rais­ing over EUR…

Researchers from Bayreuth create hyrdogel that can self-heal like human skin

A re­search team from the Universität Bayreuth and Aalto University in Fin­land has, for the first time, suc­ceeded in de­vel­op­ing a…

TUM Scientists develop a gentle, efficient method to purify proteins with light

Scient­ists at the Tech­nic­al University of Mu­nich (TUM) have de­veloped a meth­od that re­lies on phys­ics rather than con­ven­tion­al…

Erlangen University Hospital receives 600,000 US dollars in funding for translational study on CAR T-cell therapy for lupus erythematosus

More than 45 people with autoim­mune dis­eases have been suc­cess­fully treated with a novel CAR-T cell ther­apy at the University…

Formycon launches FYB202/Otulfi®, a biosimilar to Stelara®, in the United States and the European Union

For­my­con AG and its com­mer­cial­iz­a­tion part­ner Freseni­us an­nounce the com­mer­cial avail­ab­il­ity of Otulfi®1, a bi­osim­il­ar…

ONVY HealthTech Group raises over 2 million US dollars in seed funding for AI-powered health coaching

ONVY HealthTech Group GmbH, a Mu­nich-based pi­on­eer in AI-driv­en pre­ci­sion health, has suc­cess­fully raised over 2 mil­lion US…

Bavarian Nordic receives approval for first Chikungunya vaccine in Europe for people aged 12 and over

Bav­ari­an Nord­ic, with its sub­si­di­ary loc­ated in Planegg/Mu­nich, has re­ceived mar­ket­ing au­thor­iz­a­tion from the European…

Invitris wins EIC Accelerator Funding – another success for the m4 Award winner

The Martin­sried-based start-up In­vit­ris, win­ner of the m4 Award co­ordin­ated by BioM, has been se­lec­ted as one of 71 com­pan­ies in…

Formycon receives regulatory approval for FYB203 (aflibercept) in the UK

For­my­con AG and its li­cens­ing part­ner Klinge Bio­pharma GmbH have been gran­ted mar­ket­ing au­thor­isa­tion by the UK Medi­cines and…

Newsletter

Subscribe

Archive


An error occurred while rendering this content element - please try again later.


Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager